Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Type

Guidance programme

Showing 1 to 13 of 13

TitleReference numberPublishedLast updated
Asthma pathway (BTS, NICE, SIGN)NG244
Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN)NG245
Eplontersen for treating hereditary transthyretin-related amyloidosisTA1020
Pembrolizumab with chemotherapy before surgery (neoadjuvant) then alone after surgery (adjuvant) for treating resectable non-small-cell lung cancerTA1017
Fedratinib for treating disease-related splenomegaly or symptoms in myelofibrosisTA1018
Crovalimab for treating paroxysmal nocturnal haemoglobinuria in people 12 years and overTA1019
Elafibranor for previously treated primary biliary cholangitisTA1016
Endoscopic bipolar radiofrequency ablation for malignant biliary obstructionHTG731
Teclistamab for treating relapsed and refractory multiple myeloma after 3 or more treatmentsTA1015
Alectinib for adjuvant treatment of ALK-positive non-small-cell lung cancerTA1014
Endometriosis: diagnosis and managementNG73
Menopause: identification and managementNG23
Avapritinib for treating advanced systemic mastocytosisTA1012

Results per page

  1. 10
  2. 25
  3. 50
  4. All